首页> 外国专利> INJECTABLE IN-SITU CROSSLINKED HYDROGEL AND THE PREPARATION METHOD AND USE THEREOF

INJECTABLE IN-SITU CROSSLINKED HYDROGEL AND THE PREPARATION METHOD AND USE THEREOF

机译:注射用原位交联水合物及其制备方法和用途

摘要

The present invention discloses an injectable in-situ crosslinked hydrogel and its preparation method. The preparation method is as below: Filling the crosslinking active solution of at least one kind of the biocompatible macromolecules containing more than two thiol groups on the side chains into an injectable container and sealing it, and forming the in-situ disulfide-bond crosslinked hydrogel under the action of the dissolved oxygen; through controlling such parameters as partial pressure of oxygen gas, temperature and time, regulating concentration of the oxygen dissolved in the crosslinking active solution, and optimizing the gelation process and the gel properties. The present invention further relates to application of the injectable in-situ crosslinked hydrogel in pharmaceutics or surgery. The present invention has many advantages, such as no need for a crosslinking agent, simple preparation process, convenient application, containing no impurities, good biocompatibility, no toxic and side effect, and wide application in the medical science.
机译:本发明公开了一种可注射的原位交联水凝胶及其制备方法。制备方法如下:将至少一种侧链上具有两个以上巯基的生物相容性大分子的交联活性溶液填充到可注射容器中并密封,形成原位二硫键交联水凝胶。在溶解氧的作用下;通过控制氧气的分压,温度和时间等参数,调节溶解在交联活性溶液中的氧气的浓度,并优化凝胶化过程和凝胶性质。本发明进一步涉及可注射的原位交联的水凝胶在药物或手术中的应用。本发明具有不需要交联剂,制备工艺简单,使用方便,不含杂质,生物相容性好,无毒副作用等优点,在医学上具有广泛的应用。

著录项

  • 公开/公告号EP2353612B1

    专利类型

  • 公开/公告日2018-01-03

    原文格式PDF

  • 申请/专利权人 BIOREGEN BIOMEDICAL (CHANGZHOU) CO. LTD.;

    申请/专利号EP20090820182

  • 发明设计人 SHU XIAOZHENG;

    申请日2009-09-08

  • 分类号C08J3/24;A61L27/52;A61L27/54;A61L31/14;A61L31/16;A61K9;C08J3/075;

  • 国家 EP

  • 入库时间 2022-08-21 13:20:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号